MICB and neoplasm: Based on the literature, proteins such as inducible t-cell costimulatory ligand (sICOSL), cluster of differentiation 276 (sCD276), fibrinogen-like protein 1 (sFGL1), galectin-1 (sGAL-1), human MHC class I polypeptide-related sequence A (sMICA), and human MHC class I polypeptide-related sequence B (sMICB) could play an important role as immunosuppressive or immune costimulatory proteins in the tumor microenvironment, but their role in lung cancer outcomes has not yet been elucidated [30,31,32,33].